Concomitant use of renin-angiotensin system inhibitors augments the efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis.

Yu J, Meng F, Sui W, Yu J, Shen J.

Open source

DOI
10.3389/fphar.2024.1378577
Published
2024-06-04
Container
Front Pharmacol
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 18/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2024.1378577,
  title = {Concomitant use of renin-angiotensin system inhibitors augments the efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis.},
  author = {Yu J and  Meng F and  Sui W and  Yu J and  Shen J.},
  year = {2024},
  journal = {Front Pharmacol},
  doi = {10.3389/fphar.2024.1378577},
  url = {https://doi.org/10.3389/fphar.2024.1378577}
}

RIS

TY  - JOUR
TI  - Concomitant use of renin-angiotensin system inhibitors augments the efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis.
AU  - Yu J
AU  -  Meng F
AU  -  Sui W
AU  -  Yu J
AU  -  Shen J.
PY  - 2024
JO  - Front Pharmacol
DO  - 10.3389/fphar.2024.1378577
UR  - https://doi.org/10.3389/fphar.2024.1378577
ER  - 

APA

J, Y., F, M., W, S., J, Y., & J., S. (2024). Concomitant use of renin-angiotensin system inhibitors augments the efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis.. Front Pharmacol. https://doi.org/10.3389/fphar.2024.1378577

Source records